Edition:
India

Shanghai Fosun Pharmaceutical Group Co Ltd (2196.HK)

2196.HK on Hong Kong Stock

45.05HKD
15 Dec 2017
Change (% chg)

HK$-1.15 (-2.49%)
Prev Close
HK$46.20
Open
HK$45.70
Day's High
HK$45.80
Day's Low
HK$44.00
Volume
5,467,454
Avg. Vol
2,504,320
52-wk High
HK$46.25
52-wk Low
HK$22.50

Chart for

About

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products are mainly applied in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood... (more)

Overall

Beta: 0.84
Market Cap(Mil.): HK$97,674.18
Shares Outstanding(Mil.): 2,495.13
Dividend: 0.40
Yield (%): 1.14

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Ardelyx announces license agreement with Shanghai Fosun Pharmaceutical Industrial Development Co for Tenapanor in China

* Ardelyx announces license agreement with Shanghai Fosun Pharmaceutical Industrial Development Company Limited for Tenapanor in China

11 Dec 2017

BRIEF-Shanghai Fosun Pharmaceutical in agreement to set up innovation and research centre

Nov 14 Shanghai Fosun Pharmaceutical Group Co Ltd

14 Nov 2017

BRIEF-Shanghai Fosun Pharmaceutical Group unit receives approval for drug clinical trials

Nov 13 Shanghai Fosun Pharmaceutical Group Co Ltd

13 Nov 2017

BRIEF-Fosun Pharma's unit in deal to buy hospital for 909 mln yuan

Nov 12 Shanghai Fosun Pharmaceutical Group Co Ltd

12 Nov 2017

BRIEF-Shanghai Fosun Pharma Group unit receives GMP certificate

Nov 8 Shanghai Fosun Pharmaceutical Group Co Ltd :

08 Nov 2017

BRIEF-Sensus Healthcare launches SRT-100 in China for Keloid treatment

* Sensus Healthcare Inc - ‍has launched SRT-100 in China for treatment and prevention of Keloids with Chindex Medical Limited​

01 Nov 2017

BRIEF-Shanghai Fosun Pharmaceutical's 9-month net profit up 11.1 pct y/y

Oct 30 Shanghai Fosun Pharmaceutical Group Co Ltd

30 Oct 2017

BRIEF-Shanghai Fosun Pharmaceutical (Group) unit gets approval for drug clinical trial from FDA

Oct 30 Shanghai Fosun Pharmaceutical (Group) Co Ltd :

30 Oct 2017

Fosun Pharma to buy France's Tridem for $73 million

HONG KONG Shanghai Fosun Pharmaceutical (Group) Co Ltd said it would buy French drug distributor Tridem Pharma S.A.S. for 63 million euros ($73 million), in a move to expand its market share in Europe and Africa.

30 Oct 2017

Earnings vs. Estimates